Breakthrough radiation device gets clearance in US
This article was originally published in Clinica
The US FDA has cleared a device that will target tumours with a precise dose of radiation, while minimising its effects on surrounding healthy tissue.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.